Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pierce

Showing results (471-480 of 548) with videos related to

Pageof 55
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2022
FDA Approval Summary: Pembrolizumab for Neoadjuvant and Adjuvant Treatment of Patients with High-Risk Early-Stage Triple-Negative Breast CancerMirat Shah, Christy L Osgood, Anup K Amatya, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 21, 2015
One step creation of multifunctional 3D architectured hydrogels inducing bone regenerationAxel T Neffe, Benjamin F Pierce, Giuseppe Tronci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2022
FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast CancerMelanie Royce, Christy Osgood, Flora Mulkey, et al.
Plos One|November 22, 2014
A single chain variant of factor VIII Fc fusion protein retains normal in vivo efficacy but exhibits altered in vitro activityYang Buyue, Tongyao Liu, John D Kulman, et al.
The Lancet. Haematology|September 2, 2022
Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 yearsGlenn F Pierce, Megan Adediran, Saliou Diop, et al.
Cancer Research|June 11, 1999
Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in miceD L Gu, A M Gonzalez, M A Printz, et al.
Experimental Neurology|July 19, 2005
AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parametersLaura M Sanftner, Jurg M Sommer, Brian M Suzuki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2021
FDA Approval Summary: Pembrolizumab for the First-line Treatment of Patients with MSI-H/dMMR Advanced Unresectable or Metastatic Colorectal CarcinomaSandra J Casak, Leigh Marcus, Lola Fashoyin-Aje, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 29, 2015
Long-term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia AB Nolan, J Mahlangu, D Perry, et al.
Blood|March 9, 2006
Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogsHaiyan Jiang, David Lillicrap, Susannah Patarroyo-White, et al.
Pageof 55

Showing results (471-480 of 548) with videos related to

Sort By:
Pageof 55
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2022
FDA Approval Summary: Pembrolizumab for Neoadjuvant and Adjuvant Treatment of Patients with High-Risk Early-Stage Triple-Negative Breast CancerMirat Shah, Christy L Osgood, Anup K Amatya, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 21, 2015
One step creation of multifunctional 3D architectured hydrogels inducing bone regenerationAxel T Neffe, Benjamin F Pierce, Giuseppe Tronci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2022
FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast CancerMelanie Royce, Christy Osgood, Flora Mulkey, et al.
Plos One|November 22, 2014
A single chain variant of factor VIII Fc fusion protein retains normal in vivo efficacy but exhibits altered in vitro activityYang Buyue, Tongyao Liu, John D Kulman, et al.
The Lancet. Haematology|September 2, 2022
Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 yearsGlenn F Pierce, Megan Adediran, Saliou Diop, et al.
Cancer Research|June 11, 1999
Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in miceD L Gu, A M Gonzalez, M A Printz, et al.
Experimental Neurology|July 19, 2005
AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parametersLaura M Sanftner, Jurg M Sommer, Brian M Suzuki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2021
FDA Approval Summary: Pembrolizumab for the First-line Treatment of Patients with MSI-H/dMMR Advanced Unresectable or Metastatic Colorectal CarcinomaSandra J Casak, Leigh Marcus, Lola Fashoyin-Aje, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 29, 2015
Long-term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia AB Nolan, J Mahlangu, D Perry, et al.
Blood|March 9, 2006
Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogsHaiyan Jiang, David Lillicrap, Susannah Patarroyo-White, et al.
Pageof 55